{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:55:41Z","timestamp":1793404541699,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacasi.2025.06.022","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:01:19Z","timestamp":1762322479000},"page":"1428-1438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bleeding Outcomes of Ticagrelor Versus Clopidogrel in Acute Coronary Syndrome Patients"],"prefix":"10.1016","volume":"5","author":[{"given":"Guek Leng","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok Joon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganga","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Yan Yee","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Wei Chieh","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Tang","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Hwa","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Saqib","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen Su-Yin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jacasi.2025.06.022_bib1","first-page":"1193","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"45","author":"Byrne","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacasi.2025.06.022_bib2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.06.022_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.06.022_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"Kim","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacasi.2025.06.022_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1253\/circj.CJ-19-1109","article-title":"JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease","volume":"84","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2025.06.022_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4070\/kcj.2020.0196","article-title":"2020 Korean Society of Myocardial Infarction expert consensus document on pharmacotherapy for acute myocardial infarction","volume":"50","author":"Kim","year":"2020","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jacasi.2025.06.022_bib7","first-page":"285","article-title":"2020 Focused update of the 2012 Guidelines of the Taiwan Society of Cardiology for the Management of ST-Segment Elevation Myocardial Infarction","volume":"36","author":"Li","year":"2020","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jacasi.2025.06.022_bib8","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/eurheartj\/ehad362","article-title":"Personalised antiplatelet therapies for coronary artery disease: what the future holds","volume":"44","author":"Capodanno","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.06.022_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jcpt.13062","article-title":"CYP2C19 phenotype in South-East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events","volume":"45","author":"Tan","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jacasi.2025.06.022_bib10","first-page":"8","article-title":"Switching from ticagrelor to clopidogrel in Asian patients with ST-elevated myocardial infarction - a time dependent analysis study","volume":"36","author":"Koh","year":"2020","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jacasi.2025.06.022_bib11","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.06.022_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacasi.2025.06.022_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1553-2712.2011.01185.x","article-title":"Logistic regression: a brief primer","volume":"18","author":"Stoltzfus","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacasi.2025.06.022_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.06.022_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijcard.2017.10.103","article-title":"Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: the BleeMACS score","volume":"254","author":"Raposeiras-Roubin","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacasi.2025.06.022_bib16","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.06.022_bib17","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.06.022_bib18","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","article-title":"Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS","volume":"67","author":"Baber","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacasi.2025.06.022_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ehjcvp\/pvab059","article-title":"Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study","volume":"8","author":"Sarajlic","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacasi.2025.06.022_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2019.08.391","article-title":"TCT-313 incidence and impact of major bleeding events after PCI or CABG for left main coronary artery disease: the EXCEL trial","volume":"74","author":"Giustino","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.06.022_bib21","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/eurheartj\/ehr204","article-title":"Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology","volume":"32","author":"Steg","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.06.022_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.jacasi.2025.06.022_bib23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12325-020-01526-4","article-title":"Real-world bleeding and ischemic events in Asian patients on P2Y12-inhibitors after percutaneous coronary intervention: a national claims data analysis","volume":"38","author":"Lee","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacasi.2025.06.022_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cpt.2011","article-title":"Efficacy and safety of ticagrelor vs. clopidogrel in east asian patients with acute myocardial infarction: a nationwide cohort study","volume":"109","author":"Chang","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jacasi.2025.06.022_bib25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/FJC.0000000000001225","article-title":"Comparison of ticagrelor with clopidogrel in East Asian patients with acute coronary syndrome: a systematic review and meta-analysis of randomized clinical trials","volume":"79","author":"Ma","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacasi.2025.06.022_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0038-1626697","article-title":"Third-generation P2Y12 inhibitors in East Asian acute myocardial infarction patients: a nationwide prospective multicentre study","volume":"118","author":"Kang","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacasi.2025.06.022_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012078","article-title":"Safety and effectiveness of contemporary P2Y12 inhibitors in an East Asian Population with acute coronary syndrome: a nationwide population-based cohort study","volume":"8","author":"Yun","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacasi.2025.06.022_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2261-13-97","article-title":"Ethnic differences in the occurrence of acute coronary syndrome: results of the Malaysian National Cardiovascular Disease (NCVD) Database Registry (March 2006 - February 2010)","volume":"13","author":"Lu","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacasi.2025.06.022_bib29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1159\/000091189","article-title":"A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy","volume":"73","author":"Tsoumakidou","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.jacasi.2025.06.022_bib30","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/eurheartj\/ehab418","article-title":"LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project","volume":"42","author":"Yang","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.06.022_bib31","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/eurheartj\/ehab128","article-title":"Antithrombotic therapy in diabetes: which, when, and for how long?","volume":"42","author":"Ajjan","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.06.022_bib32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ahj.2014.03.009","article-title":"Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction","volume":"167","author":"Shen","year":"2014","journal-title":"Am Heart J"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725004521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725004521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T03:59:44Z","timestamp":1763783984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374725004521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772374725004521"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.06.022","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding Outcomes of Ticagrelor Versus Clopidogrel in Acute Coronary Syndrome Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}